107 related articles for article (PubMed ID: 2968011)
1. An A-chain ricin immunotoxin targeted against rat class II major histocompatibility complex molecules. In vitro and in vivo effects.
Wiley KN; Powell CS; Henry L; Clark A; Fox M
Transplantation; 1988 Jun; 45(6):1113-8. PubMed ID: 2968011
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness of anti-Ia-immunotoxins in the suppression of MLR.
Nakahara K; Kaplan D; Bjorn M; Fathman CG
Transplantation; 1985 Jul; 40(1):62-7. PubMed ID: 3160144
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of rat mixed lymphocyte pancreatic islet cultures with anti-Ia immunotoxin.
Shizuru JA; Ramakrishnan S; Hunt T; Merrell RC; Fathman CG
Transplantation; 1986 Dec; 42(6):660-6. PubMed ID: 2947362
[TBL] [Abstract][Full Text] [Related]
4. The in-vitro inhibition of rat alloantigen presentation by immunotoxins--implications for allografting.
Wiley KN; Clark A; Fox M
Clin Exp Immunol; 1989 Apr; 76(1):132-7. PubMed ID: 2525436
[TBL] [Abstract][Full Text] [Related]
5. Selective killing of tumor cells in vitro by an immunotoxin composed of ricin and monoclonal antibody against Ia antigen.
Wu M; Tang SL; Zang RJ; Yu H
Int J Immunopharmacol; 1990; 12(2):235-9. PubMed ID: 2329015
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and viability of alpha-class II immunotoxin-treated pig islet cells.
Mullen Y; Shiogama T; Ozawa A; Leonard JE; Papoian T; Tsunoda T; Terada M; Motojima K; Brown J
Transplant Proc; 1987 Feb; 19(1 Pt 2):934-6. PubMed ID: 2978886
[No Abstract] [Full Text] [Related]
7. The effectiveness of anti-Ia-immunotoxins in the suppression of MLR.
Nakahara K; Kaplan D; Bjorn M; Fathman CG
Transplantation; 1986 Aug; 42(2):205-11. PubMed ID: 2943065
[TBL] [Abstract][Full Text] [Related]
8. Organ donor or graft pretreatment to prolong allograft survival: lessons learned in the murine model.
Pollak R; Blanchard JM
Transplantation; 2000 Jun; 69(11):2432-9. PubMed ID: 10868654
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumor effects and lack of side effects in mice of an immunotoxin directed against human and mouse prostate-specific membrane antigen.
Huang X; Bennett M; Thorpe PE
Prostate; 2004 Sep; 61(1):1-11. PubMed ID: 15287089
[TBL] [Abstract][Full Text] [Related]
10. Specific inhibition of in vitro lymphocyte transformation by an anti-pan T cell (gp67) ricin A chain immunotoxin.
Kernan NA; Knowles RW; Burns MJ; Broxmeyer HE; Lu L; Lee HM; Kawahata RT; Scannon PJ; Dupont B
J Immunol; 1984 Jul; 133(1):137-46. PubMed ID: 6609971
[TBL] [Abstract][Full Text] [Related]
11. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC
Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821
[TBL] [Abstract][Full Text] [Related]
12. Pancreas-graft immunogenicity and pretreatment with anti-class II monoclonal antibodies.
Lloyd DM; Cotler SJ; Letai AG; Stuart FP; Thistlethwaite JR
Diabetes; 1989 Jan; 38 Suppl 1():104-8. PubMed ID: 2642828
[TBL] [Abstract][Full Text] [Related]
13. Abrogation of tissue immunogenicity by immunotoxin treatment of human fetal pancreas.
Hullett DA; Landry AS; Leonard DK; Sollinger HW
Transplantation; 1988 Nov; 46(5):771-3. PubMed ID: 2973671
[No Abstract] [Full Text] [Related]
14. Pharmacokinetics of an antibody-ricin conjugate administered intraperitoneally to mice.
Brusa P; Dosio F; Pacchioni D; Delprino L; Grosa G; Bussolati G; Cattel L
J Pharm Sci; 1994 Apr; 83(4):514-9. PubMed ID: 8046606
[TBL] [Abstract][Full Text] [Related]
15. Prolonged inhibition of IgE production in mice following treatment with an IgE-specific immunotoxin.
Lustgarten J; Waks T; Eshhar Z
Mol Immunol; 1996 Feb; 33(3):245-51. PubMed ID: 8649445
[TBL] [Abstract][Full Text] [Related]
16. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
Ramakrishnan S; Houston LL
Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
[TBL] [Abstract][Full Text] [Related]
17. Efficient transplantation of human non-T-leukemia cells into nude mice and induction of complete regression of the transplanted distinct tumors by ricin A-chain conjugates of monoclonal antibodies SN5 and SN6.
Hara H; Luo Y; Haruta Y; Seon BK
Cancer Res; 1988 Aug; 48(16):4673-80. PubMed ID: 2969282
[TBL] [Abstract][Full Text] [Related]
18. Bidirectional blockade of CD4 and MHC class II molecules is an effective immunosuppressive treatment.
Ito H; Hamano K; Shirasawa B; Tsuboi H; Esato K; Wood KJ
Transplant Proc; 1997; 29(1-2):1288-9. PubMed ID: 9123310
[No Abstract] [Full Text] [Related]
19. Scintigraphic detection of early cardiac rejection by iodine 123-labeled monoclonal antibody directed against monomorphic determinant of major histocompatibility complex class II antigens.
Isobe M; Southern JF; Yazaki Y
Am Heart J; 1994 May; 127(5):1309-17. PubMed ID: 7513490
[TBL] [Abstract][Full Text] [Related]
20. GUCY2C lysosomotropic endocytosis delivers immunotoxin therapy to metastatic colorectal cancer.
Marszalowicz GP; Snook AE; Magee MS; Merlino D; Berman-Booty LD; Waldman SA
Oncotarget; 2014 Oct; 5(19):9460-71. PubMed ID: 25294806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
